A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma
Abstract Programmed cell death‐1 (PD‐1) and its ligand (PD‐L1) are significant mediators of immune suppression in the tumor microenvironment. We focused on the immunological impact of PD‐1/PD‐L1 signaling during tumor progression in colorectal carcinoma (CRC) and its association with resistance to n...
Saved in:
Main Authors: | Hiroyuki Takahashi (Author), Hirono Watanabe (Author), Miki Hashimura (Author), Toshihide Matsumoto (Author), Ako Yokoi (Author), Mayu Nakagawa (Author), Yu Ishibashi (Author), Takashi Ito (Author), Kensuke Ohhigata (Author), Makoto Saegusa (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian endometrioid adenocarcinoma in a young woman with hemorrhagic shock due to tumor disintegration: A case report
by: Hiroyuki Takahashi, et al.
Published: (2016) -
Comparison of pathological response of standard chemoradiotherapy versus short course radiotherapy in rectal carcinoma: A pilot study
by: Bangalore Rammohan Nagarjun, et al.
Published: (2023) -
Synchronous papillary thyroid carcinoma with mucinous rectal carcinoma
by: Barreto S, et al.
Published: (2009) -
LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
by: Zhang Y, et al.
Published: (2021) -
Window of opportunity with PD1 blockade before chemoradiotherapy for an advanced stage clear cell carcinoma of the cervix
by: Marie-Gabrielle Courtès, et al.
Published: (2024)